Autophagy is involved in endogenous and NVP-AUY922-induced KIT degradation in gastrointestinal stromal tumors
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autophagy is involved in endogenous and NVP-AUY922-induced KIT degradation in gastrointestinal stromal tumors
Authors
Keywords
-
Journal
Autophagy
Volume 9, Issue 2, Pages 220-233
Publisher
Informa UK Limited
Online
2012-11-30
DOI
10.4161/auto.22802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Parkin-mediated K63-linked polyubiquitination: A signal for targeting misfolded proteins to the aggresome-autophagy pathway
- (2014) James A. Olzmann et al. Autophagy
- Ubiquitination and selective autophagy
- (2012) S Shaid et al. CELL DEATH AND DIFFERENTIATION
- Biogenesis and Cargo Selectivity of Autophagosomes
- (2011) Hilla Weidberg et al. Annual Review of Biochemistry
- Autophagy regulates myeloid cell differentiation by p62/SQSTM1-mediated degradation of PML-RARα oncoprotein
- (2011) Zhuo Wang et al. Autophagy
- Targeting cathepsin S induces tumor cell autophagy via the EGFR–ERK signaling pathway
- (2011) Kuo-Li Chen et al. CANCER LETTERS
- The Novel HSP90 Inhibitor, IPI-493, Is Highly Effective in Human Gastrostrointestinal Stromal Tumor Xenografts Carrying Heterogeneous KIT Mutations
- (2011) G. Floris et al. CLINICAL CANCER RESEARCH
- The Heat Shock Protein 90 Inhibitor IPI-504 Induces KIT Degradation, Tumor Shrinkage, and Cell Proliferation Arrest in Xenograft Models of Gastrointestinal Stromal Tumors
- (2011) G. Floris et al. MOLECULAR CANCER THERAPEUTICS
- Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein
- (2010) P. Isakson et al. BLOOD
- Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor
- (2010) Wei-Lien Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor
- (2010) Mrinal M. Gounder et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Sent to Destroy
- (2010) Monte S. Willis et al. CIRCULATION RESEARCH
- Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of the Combination of Sorafenib and Tanespimycin
- (2010) U. N. Vaishampayan et al. CLINICAL CANCER RESEARCH
- Selective autophagy: ubiquitin-mediated recognition and beyond
- (2010) Claudine Kraft et al. NATURE CELL BIOLOGY
- Autophagy: links with the proteasome
- (2009) Trond Lamark et al. CURRENT OPINION IN CELL BIOLOGY
- Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy
- (2009) Shensi Shen et al. JOURNAL OF CELL BIOLOGY
- Molecular Pathobiology of Gastrointestinal Stromal Sarcomas
- (2008) Christopher L. Corless et al. Annual Review of Pathology-Mechanisms of Disease
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
- (2008) D. B. Solit et al. CLINICAL CANCER RESEARCH
- Heat Shock Protein 90 Overexpression Independently Predicts Inferior Disease-Free Survival with Differential Expression of the and Isoforms in Gastrointestinal Stromal Tumors
- (2008) C.-F. Li et al. CLINICAL CANCER RESEARCH
- Heat Shock Protein 90 as a Drug Target: Some Like It Hot
- (2008) U. Banerji CLINICAL CANCER RESEARCH
- The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors
- (2008) Tzu-Yin Lin et al. EXPERIMENTAL HEMATOLOGY
- Clinical significance of oncogenicKITandPDGFRAmutations in gastrointestinal stromal tumours
- (2008) J Lasota et al. HISTOPATHOLOGY
- Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor
- (2008) Michael C. Heinrich et al. JOURNAL OF CLINICAL ONCOLOGY
- Protein kinase C-θ regulates KIT expression and proliferation in gastrointestinal stromal tumors
- (2008) W-b Ou et al. ONCOGENE
- 4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer
- (2007) Paul A. Brough et al. JOURNAL OF MEDICINAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started